Richard A Gibbs

This inventor holds 7 USPTO granted patents and 1 published patent application. Top assignees: Baylor College of Medicine, Other. Active years: 1996-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard A Gibbs. Retrieved from https://idiyas.com/inventor/richard-a-gibbs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 7 (Patent Applications = 1)

% Patents Active = 100.0

Average Co-Inventor Count = 2.2

ph-index = 6

Forward Citations = 322(Granted Patents)

Company Filing History:

6 out of 619

Baylor College of Medicine

patents

1 out of 834,601

Other

patents

Years Active: 1996-2000

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6015675 - Mutation detection by competitive oligonucleotide priming (2000-01-18),

2. 5994063 - Substituted 4,4-difluoro-4-bora-3A,4A-diaza-s-indacene compounds for (1999-11-30),

3. 5861287 - Alternative dye-labeled primers for automated DNA sequencing (1999-01-19),

4. 5728529 - Alternative dye-labeled ribonucleotides, deoxyribonucleotides, and (1998-03-17),

5. 5614386 - Alternative dye-labeled primers for automated DNA sequencing (1997-03-25),

6. 5582989 - Multiplex genomic DNA amplification for deletion detection (1996-12-10),

7. 5578458 - Mutation detection by competitive oligonucleotide priming (1996-11-26),

Title: Richard A. Gibbs: Innovator in Genetic Detection Technologies

Introduction

Richard A. Gibbs is a prominent inventor based in Houston, TX (US), known for his significant contributions to the field of genetic detection technologies. With a total of 7 patents, Gibbs has made remarkable advancements that enhance our understanding of DNA mutations and their implications.

Latest Patents

Among his latest patents, one notable invention is the "Mutation detection by competitive oligonucleotide priming." This process allows for the rapid and simple detection of mutations in DNA, facilitating the identification of differences between known DNA sequences. Another significant patent is related to "Substituted 4,4-difluoro-4-bora-3A,4A-diaza-s-indacene compounds." This invention describes the use of BODIPY™ fluorophores for detecting target nucleic acids, which are essential for various genetic assays, including the Taqman assay.

Career Highlights

Throughout his career, Richard A. Gibbs has worked with esteemed institutions, including Baylor College of Medicine. His work has been pivotal in advancing genetic research and diagnostics, contributing to the broader scientific community's understanding of genetic variations.

Collaborations

Gibbs has collaborated with notable professionals in his field, including Michael L. Metzker and Charles T. Caskey. These collaborations have further enriched his research and innovations, leading to impactful developments in genetic detection.

Conclusion

Richard A. Gibbs stands out as a key figure in the realm of genetic detection technologies. His innovative patents and collaborations have significantly contributed to advancements in understanding DNA mutations and their detection.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent pending: